Prognostic Significance of the Hemoglobin-Albumin Ratio in Upper Gastrointestinal Bleeding

ABSTRACT Objective Upper gastrointestinal bleeding is a serious and life-threatening condition where monitoring and prognosis are crucial. This study aimed to compare the prognostic value of the hemoglobin-albumin ratio (HAR) with endoscopic risk scoring systems. Methods The medical records of 153 patients with upper gastrointestinal bleeding treated at our clinic between 2022 and 2024 were retrospectively reviewed. Endoscopic risk scoring systems, including the Rockall score (RS), Glasgow-Blatchford score (GBS), and Forrest classification, were calculated. The HAR score, consisting of hematologic parameters, was computed. The HAR score was compared with clinical findings and endoscopic scores using the Mann-Whitney U and Kruskal-Wallis tests. The relationships between the HAR values and numerical variables were examined using Spearman’s correlation coefficient. Results Of the patients, 122 (79.7%) were male and 31 (20.3%) were female. A duodenal ulcer was the most common endoscopic finding (43.7%). The mean GBS was 10.69±3.89, RS was 4.37±2.27, and HAR was 2.88±0.64. There was a low-level significant correlation between the HAR score and the Glasgow Blatchford score (r=-0.254, p=0.002). Low hemoglobin levels, a low HAR score, and a high GBS were associated with a poor prognosis. Conclusion In patients with upper gastrointestinal bleeding, a low HAR score is associated with a poor prognosis. The HAR score is an effective and reliable marker, similar to endoscopic scoring systems. This study revealed a correlation between a high GBS and a low HAR score. Due to its simplicity, rapid and easy calculation, and practicality, the HAR score can be used routinely in clinical practice.